Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2525]

Outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer

Outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer

FDA approves companion diagnostic test to identify NTRK fusions in solid tumours for vitrakvi

FDA approves companion diagnostic test to identify NTRK fusions in solid tumours for vitrakvi

18F-Fluciclovine PET/MRI for prostate cancer staging, androgen deprivation evaluation

18F-Fluciclovine PET/MRI for prostate cancer staging, androgen deprivation evaluation

Adding advanced PET scans to radiation plans for prostate cancer increases FFS rates

Adding advanced PET scans to radiation plans for prostate cancer increases FFS rates

Gemcitabine and daily radiotherapy for bladder preservation in muscle-invasive bladder cancer

Gemcitabine and daily radiotherapy for bladder preservation in muscle-invasive bladder cancer

ASTRO highlightsWinship study showing increased failure-free survival in prostate cancer

ASTRO highlightsWinship study showing increased failure-free survival in prostate cancer

Hand-held device reads levels of cancer biomarker

Hand-held device reads levels of cancer biomarker

Researchers uncover new way to personalise treatments for prostate cancer

Researchers uncover new way to personalise treatments for prostate cancer

Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer

Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer

Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

More from ecancer